原料品名 URSODEOXYCHOLIC ACID (250MG. TABLETS) 原料中文名称 熊去氧胆酸 化学名称 (3R,4R,6R)-6-[(4R)-4-[(3R,5S,7S,8R,9R,10S,13R,14R,17S)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]...
Ursofalk(URSODEOXYCHOLIC ACID)-胆固醇性结石溶石治疗和胆汁淤积性肝病的首选药物 优思佛Ursofalk成份活性成份:一粒胶囊含胶氧熊胆酸250mg 其他成份:乳浆化赋形剂适应证1.胆固醇性胆囊结石-结石必须是X射线能穿透的,同时胆囊收缩功能须正常; 2.胆汁返流性胃炎; 3.对于胆结石钙化病人出现胆管痉孪或胆绞痛时,不能用本...
Festal Plus Ursodeoxycholic acid (10 mg/1) + Dimethicone (30 mg/1) + Pancrelipase (315 mg/1) Tablet Oral OASIS TRADING 2018-11-21 Not applicable Urusa Ursodeoxycholic acid (250 mg/1) Capsule Oral OASIS TRADING 2018-11-15 Not applicable ...
Capsules; Oral; Ursodeoxycholic Acid 250 mg Tablets, Film-Coated; Oral; Ursodeoxycholic Acid 150 mg Tablets, Film-Coated; Oral; Ursodeoxycholic Acid 300 mg Medical categories: Human: Cholagogues, cholelitholytics and hepatic protectors Cholelitholytic agents ...
URSODEOXYCHOLIC ACID 300MG FILM-COATED TABLETS (Leaflet) Scheme Rec.INN ATC (Anatomical Therapeutic Chemical Classification) A05AA02 CAS registry number (Chemical Abstracts Service) 0000128-13-2 Chemical Formula C24-H40-O4 Molecular Weight 393 ...
Ursodeoxycholsäure; Acide ursodésoxycholique; Ácido ursodesoxicólico; 우르 소데 옥시 콜산; ウルソデオキシコール酸; (3α,5β,7β)-3,7-Dihydroxycholan-24-oic acid; (4R)-4-[(3R,5S,7S,8R,9S,10R,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,...
3β-熊去氧胆酸 3β-Ursodeoxycholic acid 78919-26-3 维克奇 价格电议 起批量≥1 毫克 最小起订1毫克 供货总量10000毫克 发货地址四川省成都市 建议售价￥10/毫克 更新日期2025年02月10日 产品规格20mg/支 即时洽谈立即询价查看联系方式 收藏产品发送留言 ...
if the dose increases from 250mg to 500mg, the serum ursodeoxycholic acid increases by 250×0.063=15.75. There was excellent reproducibility for the AUC for the North American tablets (0.97, 0.88) compared to the two capsules (0.32, 0.15). Conclusions: The significantly higher AUC and C max...
10–15 mg/kg q.24 h or divided and given q.12 h It is recommended thatursodeoxycholic acidbe administered for 3–4 months, after which the patient should be reassessed for improvement inbiochemical markersof hepatocellular pathology. If there has been improvement treatment is continued but if ...
if the dose increases from 250mg to 500mg, the serum ursodeoxycholic acid increases by 250脳0.063=15.75. There was excellent reproducibility for the AUC for the North American tablets (0.97, 0.88) compared to the two capsules (0.32, 0.15). Conclusions: The significantly higher AUC and C max...